← Open Payments lookup

ABIGAEL DOLLENS: Open Payments

NPI 1023721289 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,567 in 89 payments from 16 companies in 2025. Trend: 2023 $607 · 2024 $772 · 2025 $1,567

Food & beverage: $1,567
CompanyPaymentsAmount
Novo Nordisk Inc21$325
Lilly USA, LLC15$224
ABBVIE INC.10$173
Axsome Therapeutics, Inc.5$154
Amgen Inc.10$149
PFIZER INC.7$140
Supernus Pharmaceuticals, Inc.4$90
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$59
Corium, LLC2$53
AstraZeneca Pharmaceuticals LP3$48

Products named: MOUNJARO, Wegovy, Auvelity, Ozempic, PREVNAR 20, OTEZLA, UBRELVY, Qelbree.

Industry payments across TX — which companies pay providers there.